Company Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins.
It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening.
The company also provides biocatalyst screening and protein engineering services.
In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.
The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes.
It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe.
The company was incorporated in 2002 and is headquartered in Redwood City, California.
| Country | United States |
| IPO Date | Apr 22, 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 174 |
| CEO | Dr. Stephen George Dilly MBBS, Ph.D. |
Contact Details
Address: 200 Penobscot Drive Redwood City, California United States | |
| Website | https://www.codexis.com |
Stock Details
| Ticker Symbol | CDXS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001200375 |
| CUSIP Number | 192005106 |
| ISIN Number | US1920051067 |
| Employer ID | 71-0872999 |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Dr. Stephen George Dilly MBBS, Ph.D. | President, Chief Executive Officer & Chairman |
| Dr. Alison Moore Ph.D. | Chief Technology Officer |
| Georgia L. Erbez | Chief Financial Officer |
| Kevin Norrett M.B.A., M.S. | Chief Operating Officer |
| Carrie McKim | Director of Investor Relations |
| Dr. Stefan Lutz Ph.D. | Senior Vice President of Research |
| John Schiffhauer | Senior Vice President of Intellectual Property |
| Karen Frechou-Armijo | Senior Vice President & Head of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SCHEDULE 13G/A | [Amend] Filing |
| Nov 12, 2024 | 4 | Filing |
| Nov 12, 2024 | 3 | Filing |
| Nov 12, 2024 | 8-K | Current Report |
| Oct 31, 2024 | 10-Q | Quarterly Report |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 28, 2024 | 4 | Filing |
| Oct 22, 2024 | 8-K | Current Report |
| Oct 10, 2024 | 4 | Filing |
| Oct 10, 2024 | 4 | Filing |